Metastases of colorectal cancer to the liver and peritoneum: Comparison of surgical paradigms

Expert Review of Anticancer Therapy

Volumn 8, Issue 11, 2008, Pages 1797-1808

  Shen, Perry ^a   Stewart, John H ^a   Levine, Edward A ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Colorectal cancer; Hepatic metastase; Intraperitoneal hyperthermic chemotherapy; Peritoneal surface disease

Indexed keywords

ANTINEOPLASTIC AGENT; FLUOROURACIL; FOLINIC ACID; IRINOTECAN; MITOMYCIN C;

AGE DISTRIBUTION; CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; COLORECTAL CANCER; COMPARATIVE STUDY; CYTOREDUCTIVE SURGERY; DRUG INDICATION; EVIDENCE BASED PRACTICE; HUMAN; INTRAPERITONEAL HYPERTHERMIC CHEMOTHERAPY; LIVER METASTASIS; LIVER RESECTION; LYMPH NODE METASTASIS; MEDICAL DECISION MAKING; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PATIENT SAFETY; PATIENT SELECTION; PERITONEUM METASTASIS; POSTOPERATIVE COMPLICATION; PRACTICE GUIDELINE; PREOPERATIVE CARE; PREOPERATIVE EVALUATION; PROGNOSIS; REOPERATION; REVIEW; SEX DIFFERENCE; STANDARDIZATION; SURGICAL MORTALITY; SURVIVAL RATE; SURVIVAL TIME; TREATMENT INDICATION;

ANIMALS; COLORECTAL NEOPLASMS; HUMANS; LIVER NEOPLASMS; PERITONEAL NEOPLASMS; SURVIVAL RATE;

EID: 60849091101     PISSN: 14737140     EISSN: 17448328     Source Type: Journal    
DOI: 10.1586/14737140.8.11.1797     Document Type: Review

References (37)

1. Kelly H, Goldberg RM. Systemic therapy for metastatic colorectal cancer: current options, current evidence. J. Clin. Oncol. 23, 4553-4560 (2005).
2. Hughes KS, Rosenstein RB, Songhorabodi S et al. Resection of the liver for colorectal carcinoma metastases. A multi-institutional study of long-term survivors. Dis. Colon Rectum 31, 1-4 (1988).
3. Scheele J, Stang R, Altendorf-Hofmann A, Paul M. Resection of colorectal liver metastases. World J. Surg. 19, 59-71 (1995).
4. Rosen CB, Nagorney DM, Taswell HF et al. Perioperative blood transfusion and determinants of survival after liver resection for metastatic colorectal carcinoma. Ann. Surg. 216, 493-504 (1992).
5. Gayowski TJ, Iwatsuki S, Madariaga JR et al. Experience in hepatic resection for metastatic colorectal cancer: analysis of clinical and pathologic risk factors. Surgery 116, 703-710 (1994).
6. Nordlinger B, Guiguet M, Vaillant JC et al. Surgical resection of colorectal carcinoma metastases to the liver. A prognostic scoring system to improve case selection, based on 1568 patients. Association Française de Chirurgie. Cancer 77, 1254-1262 (1996).
7. Jamison RL, Donohue JH, Nagorney DM, Rosen CB, Harmsen WS, Ilstrup DM. Hepatic resection for metastatic colorectal cancer results in cure for some patients. Arch. Surg. 132, 505-510 (1997).
8. Fong Y, Fortner J, Sun RL, Brennan MF, Blumgart LH. Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann. Surg. 230, 309-318 (1999).
9. Choti MA, Sitzmann JV, Tiburi MF et al. Trends in long-term survival following liver resection for hepatic colorectal metastases. Ann. Surg. 235, 759-766 (2002).
10. Rees M, Tekkis PP, Welsh FK, O'Rourke T, John TG. Evaluation of long-term survival after hepatic resection for metastatic colorectal cancer: a multifactorial model of 929 patients. Ann. Surg. 247, 125-135 (2008).
11. Adam R, Delvart V, Pascal G et al. Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival. Ann. Surg. 240, 644-658 (2004).
12. Sugarbaker PH, Jablonski KA. Prognostic features of 51 colorectal and 130 appendiceal cancer patients with peritoneal carcinomatosis treated by cytoreductive surgery and intraperitoneal chemotherapy. Ann. Sury. 221, 124-132 (1995).
13. Loggie BW, Fleming RA, McQuellon RP, Russell GB, Geisinger KR. Cytoreductive surgery with intraperitoneal hyperthermic chemotherapy for disseminated peritoneal cancer of gastrointestinal origin. Am. Surg. 66, 561-568 (2000).
14. Pestieau SR, Sugarbaker PH. Treatment of primary colon cancer with peritoneal carcinomatosis: comparison of concomitant vs. delayed management. Dis. Colon Rectum 43, 1341-1348 (2000).
15. Elias D, Blot F, El Otmany A et al. Curative treatment of peritoneal carcinomatosis arising from colorectal cancer by complete resection and intraperitoneal chemotherapy. Cancer 92, 71-76 (2001).
16. Shen P, Hawksworth J, Lovato J et al. Cytoreductive surgery and intraperitoneal hyperthermic chemotherapy with mitomycin C for peritoneal carcinomatosis from nonappendiceal colorectal carcinoma. Ann. Surg. Oncol. 11, 178-186 (2004).
17. Glehen O, Kwiatkowski F, Sugarbaker PH et al. Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multi-institutional study. J. Clin. Oncol. 22, 3284-3292 (2004).
18. Verwal VJ, van Ruth S, de Bree et al. Randomized trial of cytoreduction and hyptrthermic intraperitoneal chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. J. Clin. Oncol. 21, 3737-3743 (2003).
19. Armstrong DK, Bundy B, Wenzel L et al. Intraperitoneal cisplatin and paclitaxel in ovarian cancer. N. Engl. J. Med. 354, 34-43 (2006).
20. Esquivel J, Sticca R, Sugarbaker P et al. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of peritoneal surface malignancies of colonic origin: a consensus statement. Ann. Surg. Oncol. 14, 128-133 (2007).
21. Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann. Surg. 240, 205-213 (2004).
22. Gertsch P. A historical perspective on colorectal liver metastases and peritoneal carcinomatosis: similar results, different treatments. Surg. Oncol. Clin. North Am. 12, 531-541 (2003).
23. Scheele J, Altendorf-Hofmann A. Surgical Treatment of liver metastases. In: Surgery of the Liver and Biliary Tract (3rd Edition). Blumgart LH, Fong Y (Eds). WB Saunders, London, UK 1475-1502 (2000).
24. Dawson LE, Russell AH, Tong D, Wisbeck WM. Adenocarcinoma of the sigmoid colon: sites of initial dissemination and clinical patterns of recurrence following surgery alone. J. Surg. Oncol. 22, 95-99 (1983).
25. Chu DZ, Lang NP, Thompson C, Osteen PK, Westbrook KC. Peritoneal carcinomatosis in nongynecologic malignancy. A prospective study of prognostic factors. Cancer 15(63), 364-367 (1989).
26. Knorr C, Reingruber B, Meyer T, Hohenberger W, Stremmel C. Peritoneal carcinomatosis of colorectal cancer: incidence, prognosis, and treatment modalities. Int. J. Colorectal Dis. 19, 181-187 (2064).
27. Improved survival with pereoperative radiotherapy in resectable rectal cancer. Swedish Rectal Cancer Trial. N. Engl. J. Med. 3, 336, 980-987 (1997).
28. Wei AC, Greig PD, Grant D, Taylor B, Langer B, Gallinger S. Survival after hepatic resection for colorectal metastases: a 10-year experience. Ann. Surg. Oncol. 13(5), 668-676 (2006).
29. Wei AC, Greig PD, Grant D, Taylor B, Langer B, Gallinger S. Survival after hepatic resection for colorectal metastases. a 10-year experience Ann. Surg. Oncol. 13(5), 668-676 (2006).
30. Figueras J. Torras J, Valls C et al. Surgical resection of colorectal liver metastases in patients with expanded indications: a single-center experience with 501 patients. Dis. Colon Rectum 50(4), 478-488 (2007).
31. Tomlinson JS, Jarnagin WR, DeMatteo RP et al. Actual 10-year survival after resection of colorectal liver metastases defines cure. J. Clin. Oncol. 25(29), 4575-4580 (2007).
32. Kianmanesh R, Scaringi S, Sabate JM et al. Iterative cytoreductive surgery associated with hyperthermic intraperitoneal chemotherapy for treatment of pcritoneal carcinomatosis of colorectal origin with or without liver metastases. Ann Surg 245(4), 597-603 (2007).
33. Verwaal VJ, Bruin S, Boot H, Slooten GV, Tinteren HV. 8-year follow-up of randomized trial: cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer. Ann. Surg. Oncol. 15(9), 2426-2432 (2008).
34. Witkamp AJ, de Bree E, Van Goethem R, Zoetmulder FA. Rationale and techniques of intra-operative hyperthermic intraperitoneal chemotherapy. Cancer Treat. Rev. 27, 365-374 (2001).
35. MeQuellon RP, Danhauer SC, Russell GB et al. Monitoring health outcomes following cytoreductive surgery plus intraperitoneal hyperthermic chemotherapy for peritoneal carcinomatosis. Ann. Surg. Oncol. 14(3), 1105-1113 (2007).
36. Lincourt AE, Sing RF, Kercher KW et al. Association of demographic and treatment variables in long-term colon cancer survival. Surg. Innov. 15, 17-25 (2008).
37. Shen P, Thai K, Stewart JH et al. Peritoneal surface disease from colorectal cancer: comparison with the hepatic metastases surgical paradigm in optimally resected patients. Ann. Surg. Oncol. DOI: 10.1245/s10434-008-0127-4. (2008) (Epub ahead of print).